drugset / Trial / NCT02055963
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
RandomizedParallel-groupDouble-blindSupportive care
Summary
The goal of this clinical research study is to learn if Minocin® (minocycline) can reduce certain side effects of surgery in patients with head and neck cancer (such as pain, fatigue, and disturbed sleep). In this study, minocycline will be compared to a placebo. A placebo is not a drug. It looks like the study drug, but it is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.
Timeline
- Start
- 2014-05-06
- Primary completion
- 2022-08-11
- Completion
- 2022-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 100 mg | Oral |